Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:HTWR's 10-Y Financials

Financials (Next Earnings Date: 0)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HTWR Guru Trades in Q4 2015

Jim Simons 50,000 sh (New)
Steven Cohen Sold Out
» More
Q1 2016

HTWR Guru Trades in Q1 2016

Michael Price 30,000 sh (New)
Jim Simons 192,448 sh (+284.90%)
» More
Q2 2016

HTWR Guru Trades in Q2 2016

Paul Tudor Jones 55,000 sh (New)
Mario Gabelli 58,550 sh (New)
Chuck Royce 10,000 sh (New)
Michael Price Sold Out
Jim Simons 181,700 sh (-5.58%)
» More
Q3 2016

HTWR Guru Trades in Q3 2016

Paul Tudor Jones Sold Out
Chuck Royce Sold Out
Jim Simons Sold Out
Mario Gabelli Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HTWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Compare:NAS:VASC, NAS:MDXG, NAS:CSII, NAS:KTWO, NAS:CNMD, NYSE:ITGR, NAS:SPNC, NAS:BABY, NAS:OFIX, OTCPK:SBMAF, OTCPK:MZRTF, NAS:GNMK, NYSE:CRY, OTCPK:NMRD, NAS:XENT, NAS:VRAY, NAS:CYNO, OTCPK:IOBCF, NAS:INGN, NAS:ARAY » details
Traded in other countries:HIN.Australia, HIY1.Germany,
Headquarter Location:USA
Heartware International Inc is a medical device company. It develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of heart failure.

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $257.0
EPS (TTM) $ -3.40
Short Percentage of Float5.11%
52-Week Range $25.02 - 87.38
Shares Outstanding (Mil)17.56

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 240 260 307
EPS ($) -3.66 -2.97 -2.32
EPS without NRI ($) -3.66 -2.97 -2.32
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for HTWR

Headlines

Articles On GuruFocus.com
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Heartware Internatio Jan 26 2016 
Bernstein Litowitz Berger & Grossmann LLP Issues Corrected Notice to Clarify Case Caption in Securit Jan 25 2016 
Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Heart Jan 22 2016 
Weekly Three-Year Low Highlights: Gap, NRG Energy, Buckle, HeartWare International Oct 13 2015 
Baron Funds Comments on HeartWare International May 05 2014 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares Feb 24 2011 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares Apr 30 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares Mar 09 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares Feb 26 2010 
Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares Jan 29 2010 

More From Other Websites
Ranking the Activists for Proxy Season 2016 Dec 01 2016
Medtronic’s HeartWare Acquisition: The Must-Know Details Aug 31 2016
Medtronic's HeartWare Takeover Complete for $1.1 Billion Aug 24 2016
ETF’s with exposure to HeartWare International, Inc. : August 22, 2016 Aug 22 2016
HeartWare International, Inc. :HTWR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 Aug 09 2016
HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue Jul 28 2016
Medtronic’s Heartware Acquisition: Portfolio Impact Jul 08 2016
HeartWare (HTWR) Stock Downgraded at Barclays Jun 29 2016
Why Is Medtronic Acquiring Heartware? Jun 29 2016
INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of HeartWare... Jun 28 2016
Medtronic Global Holdings SCA -- Moody's: Medtronic's HeartWare Deal and Dividend Increase are... Jun 28 2016
HeartWare International, Inc. Acquisition May Not Be in the Best Interests of HTWR Shareholders Jun 28 2016
Company News for June 28, 2016 Jun 28 2016
Medtronic to Boost Heart Failure Business with HeartWare Buy Jun 28 2016
Why Heartware International, GW Pharmaceuticals, and Randgold Resources Jumped Today Jun 27 2016
INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into the Fairness of the Sale of... Jun 27 2016
Medtronic to Buy HeartWare for $1.1 Billion (MDT, HTWR) Jun 27 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)